Noa Avisar

448 total citations
18 papers, 341 citations indexed

About

Noa Avisar is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Noa Avisar has authored 18 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Noa Avisar's work include Neutropenia and Cancer Infections (8 papers), Neuroscience and Neuropharmacology Research (3 papers) and Cancer therapeutics and mechanisms (3 papers). Noa Avisar is often cited by papers focused on Neutropenia and Cancer Infections (8 papers), Neuroscience and Neuropharmacology Research (3 papers) and Cancer therapeutics and mechanisms (3 papers). Noa Avisar collaborates with scholars based in Israel, United States and Russia. Noa Avisar's co-authors include Lily Vardimon, Iftach Shaked, Nili Avidan, Iris Ben‐Dror, Jeffrey H. Peters, Oleg Gladkov, Igor Bondarenko, Steve Barash, Vladimir Moiseyenko and Peter Bias and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Noa Avisar

17 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noa Avisar Israel 9 121 101 52 50 48 18 341
Michael Ahmadi Germany 9 175 1.4× 38 0.4× 22 0.4× 21 0.4× 34 0.7× 12 409
Xiaoxia Li China 9 273 2.3× 40 0.4× 27 0.5× 44 0.9× 49 1.0× 13 553
Maya Mikami United States 12 223 1.8× 57 0.6× 11 0.2× 30 0.6× 22 0.5× 19 435
Judith A. Herlein United States 12 248 2.0× 56 0.6× 26 0.5× 12 0.2× 24 0.5× 13 584
Yanmin Song China 12 200 1.7× 48 0.5× 11 0.2× 18 0.4× 47 1.0× 30 425
Silke Wiegand Germany 11 226 1.9× 110 1.1× 26 0.5× 10 0.2× 17 0.4× 18 506
Thomas Grüter Germany 14 57 0.5× 167 1.7× 16 0.3× 59 1.2× 14 0.3× 43 425
Jinzhou Feng China 14 170 1.4× 94 0.9× 17 0.3× 9 0.2× 23 0.5× 37 470
Claire Tronel France 9 150 1.2× 74 0.7× 23 0.4× 33 0.7× 12 0.3× 9 381
Ayako Ishida Japan 13 131 1.1× 100 1.0× 14 0.3× 43 0.9× 14 0.3× 24 369

Countries citing papers authored by Noa Avisar

Since Specialization
Citations

This map shows the geographic impact of Noa Avisar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Avisar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Avisar more than expected).

Fields of papers citing papers by Noa Avisar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noa Avisar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Avisar. The network helps show where Noa Avisar may publish in the future.

Co-authorship network of co-authors of Noa Avisar

This figure shows the co-authorship network connecting the top 25 collaborators of Noa Avisar. A scholar is included among the top collaborators of Noa Avisar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noa Avisar. Noa Avisar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mor‐Avi, Victor, Bijoy K. Khandheria, Robert Klempfner, et al.. (2023). Real-Time Artificial Intelligence–Based Guidance of Echocardiographic Imaging by Novices: Image Quality and Suitability for Diagnostic Interpretation and Quantitative Analysis. Circulation Cardiovascular Imaging. 16(11). e015569–e015569. 35 indexed citations
2.
Lang, Roberto M., Victor Mor‐Avi, Juan Ignacio Cotella, et al.. (2023). NOVEL ARTIFICIAL INTELLIGENCE GUIDANCE ALGORITHM ENABLES ACQUISITION BY NOVICES OF DIAGNOSTIC QUALITY ECHOCARDIOGRAPHIC IMAGES. Journal of the American College of Cardiology. 81(8). 1401–1401. 1 indexed citations
3.
Reddy, Vivek Y., Aharon Abbo, Carlos E. Ruiz, et al.. (2020). First-in-Human Percutaneous Circumferential Annuloplasty for Secondary Tricuspid Regurgitation. SHILAP Revista de lepidopterología. 2(14). 2176–2182. 9 indexed citations
4.
Avisar, Noa, et al.. (2015). First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy. Cancer Chemotherapy and Pharmacology. 75(5). 929–939. 4 indexed citations
5.
Gladkov, Oleg, Vladimir Moiseyenko, Igor Bondarenko, et al.. (2015). Phase II dose-finding study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy. Medical Oncology. 32(6). 623–623. 10 indexed citations
6.
Avisar, Noa, et al.. (2015). A thorough QT study to assess the effects of tbo-filgrastim on cardiac repolarization in healthy subjects. Drug Design Development and Therapy. 9. 2653–2653. 1 indexed citations
7.
Gladkov, Oleg, Vladimir Moiseyenko, Igor Bondarenko, et al.. (2015). A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel. The Oncologist. 21(1). 7–15. 21 indexed citations
8.
Volovăț, Constantin, Oleg Gladkov, Igor Bondarenko, et al.. (2013). Efficacy and Safety of Balugrastim Compared With Pegfilgrastim in Patients With Breast Cancer Receiving Chemotherapy. Clinical Breast Cancer. 14(2). 101–108. 19 indexed citations
9.
Pukac, Laurie, Steven Barash, Noa Avisar, et al.. (2013). Balugrastim: A long-acting, once-per-cycle, recombinant human albumin-fusion filgrastim.. Journal of Clinical Oncology. 31(15_suppl). e13551–e13551. 2 indexed citations
10.
Avisar, Noa, Laurie Pukac, Steve Barash, et al.. (2013). Recombinant Albumin-Partnering Technology: Development Of Balugrastim, a Novel Long-Acting Granulocyte Colony-Stimulating Factor. Blood. 122(21). 4854–4854. 4 indexed citations
11.
Volovăț, Constantin, Oleg Gladkov, Igor Bondarenko, et al.. (2012). Efficacy and safety of balugrastim compared with pegfilgrastim in patients with breast cancer who are receiving chemotherapy.. Journal of Clinical Oncology. 30(15_suppl). 9125–9125. 4 indexed citations
12.
13.
Peters, Jeffrey H. & Noa Avisar. (2009). The Molecular Pathogenesis of Barrett’s Esophagus: Common Signaling Pathways in Embryogenesis Metaplasia and Neoplasia. Journal of Gastrointestinal Surgery. 14. S81–S87. 20 indexed citations
14.
Vardimon, Lily, et al.. (2001). Regulation of glutamine synthetase in normal and injured neural tissues. 2(2-3). 83–88. 1 indexed citations
15.
Avisar, Noa, et al.. (1999). A Silencer Element in the Regulatory Region of Glutamine Synthetase Controls Cell Type-specific Repression of Gene Induction by Glucocorticoids. Journal of Biological Chemistry. 274(16). 11399–11407. 28 indexed citations
16.
Vardimon, Lily, et al.. (1999). Glucocorticoid control of glial gene expression. Journal of Neurobiology. 40(4). 513–527. 59 indexed citations
17.
Vardimon, Lily, et al.. (1997). Glutamine synthetase protects against neuronal degeneration in injured retinal tissue. Neuroscience Letters. 237. S50–S51. 4 indexed citations
18.
Avidan, Nili, et al.. (1997). Glutamine synthetase protects against neuronal degeneration in injured retinal tissue. Proceedings of the National Academy of Sciences. 94(13). 7024–7029. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Ahmadi Breakdown of academic impact, for papers by Xiaoxia Li Breakdown of academic impact, for papers by Maya Mikami Breakdown of academic impact, for papers by Judith A. Herlein Breakdown of academic impact, for papers by Yanmin Song Breakdown of academic impact, for papers by Silke Wiegand Breakdown of academic impact, for papers by Thomas Grüter Breakdown of academic impact, for papers by Jinzhou Feng Breakdown of academic impact, for papers by Claire Tronel Breakdown of academic impact, for papers by Ayako Ishida
Rankless by CCL
2026